16/05/2023

Mast cells have an important impact on the development of chronic myeloid leukemia

Research team at the University of Freiburg and the German Cancer Consortium (DKTK), partner site Freiburg, identifies the origin of proinflammatory cytokines in chronic myeloid leukemia (CML). The…

08/05/2023

Study sheds light on the mysterious evolution of DNA rings

Tumors sometimes seem to take on a life of their own, growing at an unusually fast rate or suddenly developing resistance to a cancer drug. This behavior is often explained by cancer genes separating…

03/05/2023

Diabetes, Cancer & Neurodegenerative Diseases - 5th Joint Dresden DZG Symposium unites Dresden researchers

A total of more than 80 institutions with numerous participating universities, university hospitals and non-university research facilities make up the German Centers for Health Research. Three of them…

28/04/2023

4th Rhein-Main Cancer Retreat (RMCR)

Exchange and networking between the disciplines of basic and translational cancer research was again the focus of the 4th Rhein-Main Cancer Retreat (RMCR) on March 16 and 17, 2023.

19/04/2023

Multiplexed Ion Beam Imaging (MIBI) & its applications in cancer research

Scientists have to deal with the complex microenvironment of tumors, which includes immune cells, fibroblasts and other components. In the DKTK School of Oncology's first Tech Talk of 2023 on March…

30/03/2023

German Centers for Health Research support declaration on patient participation of the Health Research Forum

Patients can participate in medical research as active partners. Researchers should consider their needs and their unique expertise in the research process, as it is a valuable resource. The Health…

20/03/2023

Overcoming professional boundaries - DZG fund joint project on gene and cell therapy

This is what ideal medicine would look like: Doctors could specifically alter molecular processes in diseased cells in the body and thus causally cure patients. This is the goal of the German Centers…

16/03/2023

New targets for CAR-T cell therapy against acute myeloid leukemia through AI-assisted analysis

Unlike other forms of blood cancer, acute myeloid leukemia (AML) cannot currently be treated with CAR-T cell immunotherapy. The reason is that specific molecular targets with which certain immune…

07/03/2023

New functions discovered for wellknown cancer driver

The transcription factor SNAIL is an old acquaintance in the context of the spread of tumors. Scientists from the German Cancer Consortium (DKTK) and the Technical University of Munich (TUM) are now…

27/02/2023

Spatial Biology Lab @ Edinger Institute

At the end of 2022, a "Spatial Biology Lab" was established at the Edinger Institute (director: Prof. Karl H. Plate) with the support of the research networks of the LOEWE Center Frankfurt Cancer…

20/02/2023

Liver cancer research: iron-dependent cell death could be the key to novel combination therapies

Iron-dependent cell death (ferroptosis) is a type of programmed cell death by means of which the body kills off diseased, defective or superfluous cells. This process can be used to make…

27/01/2023

What keeps the immune defense in brain tumors functional

Cancer immunotherapies often fail because the immune cells are paralysed by immunosuppressive conditions in the tumor. Scientists from Heidelberg, Mannheim and Tel Aviv have now shown on tissue…

13/01/2023

Cancer in children: New treatment opportunities through drug testing on mini-tumors

One fifth of all children suffering from cancer still die because standard therapies are no longer effective in the event of a relapse. A team of researchers from the Hopp Children's Cancer Center…

23/12/2022

DKTK Tech Talk: Analysis of clonogenic growth in vitro – Dinosaur technique or still up-to-date?

16/12/2022

How brain tumors keep the beat - and why that makes them so dangerous

Scientists from Heidelberg University Hospital, the German Cancer Research Center and the German Cancer Consortium describe tumor cells with pacemaker function in highly aggressive glioblastomas in…

15/12/2022

Possible therapeutic approach to fight incurable blood cancer

Multiple myeloma (MM) is the second most common type of blood cancer. It attacks the plasma cells in the blood. A team at the Technical University of Munich (TUM) including scientists from the German…

09/12/2022

Leibniz Prize for Stefan Pfister

Prof. Dr. Stefan Pfister, Director of the Hopp Children's Cancer Center Heidelberg (KiTZ), Head of Department at the German Cancer Research Center (DKFZ) and Professor at the Heidelberg University…

05/12/2022

Cancer researcher Ulrike Stein receives high honor

Ulrike Stein is searching for molecules that play a key role in metastasis, aiming to use them as therapeutic targets for solid tumors and to improve cancer prognosis. The Metastasis Research Society…

28/11/2022

Sinonasal cancer: AI facilitates breakthrough in diagnostics

Researchers at LMU Munich and Charité hospital in Berlin have developed a method for classifying difficult-to-diagnose nasal cavity tumors using artificial intelligence (AI) to analyze chemical…

04/11/2022

REVEAL- New Potential Target Structures in Metastasized Colorectal Cancer

The biomarker study REVEAL, funded by the German Cancer Consortium (DKTK), coordinated by PD Dr. Julian Holch, DKTK partner site Munich, and Prof. Dr. Reinhold Schäfer, DKTK partner site Berlin,…